Oki E - Search Results

1

Infusion-related reaction to ramucirumab plus FOLFIRI in patients with advanced colorectal cancer.

Okuyama H, Kagawa Y, Masuishi T, Mishima S, Shirasu H, Ando K, Yuki S, Muro K, Yoshino T, Yamazaki K, Oki E, Komatsu Y, Tsuji A. Okuyama H, et al. Among authors: oki e. Int J Clin Oncol. 2021 Nov;26(11):2025-2028. doi: 10.1007/s10147-021-02004-9. Epub 2021 Sep 2. Int J Clin Oncol. 2021. PMID: 34476649

2

Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer.

Takahashi I, Emi Y, Kakeji Y, Tokunaga E, Ushiro S, Oki E, Watanabe M, Baba H, Maehara Y. Takahashi I, et al. Among authors: oki e. Oncol Rep. 2006 Apr;15(4):849-54. Oncol Rep. 2006. PMID: 16525670 Clinical Trial.

3

Trastuzumab and breast cancer: developments and current status.

Tokunaga E, Oki E, Nishida K, Koga T, Egashira A, Morita M, Kakeji Y, Maehara Y. Tokunaga E, et al. Among authors: oki e. Int J Clin Oncol. 2006 Jun;11(3):199-208. doi: 10.1007/s10147-006-0575-4. Int J Clin Oncol. 2006. PMID: 16850126 Review.

4

[Combination chemotherapy of S-1 plus biweekly docetaxel for advanced and recurrent gastric cancer].

Takahashi I, Oki E, Egashira A, Morita M, Kakeji Y, Maehara Y. Takahashi I, et al. Among authors: oki e. Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:87-90. Gan To Kagaku Ryoho. 2006. PMID: 16897979 Review. Japanese.

5

[Hepatic artery infusion chemotherapy to three liver metastasis cases in which systemic chemotherapy was impossible or ineffective].

Ando K, Oki E, Kakeji Y, Sugiyama M, Saeki H, Endo K, Morita M, Emi Y, Maehara Y. Ando K, et al. Among authors: oki e. Gan To Kagaku Ryoho. 2008 Nov;35(12):2192-4. Gan To Kagaku Ryoho. 2008. PMID: 19106567 Japanese.

6

Salvage esophagectomy after definitive chemoradiotherapy for synchronous double cancers of the esophagus and head-and-neck.

Yoshida R, Morita M, Ando K, Masuda T, Saeki H, Oki E, Sadanaga N, Nakashima T, Kakeji Y, Maehara Y. Yoshida R, et al. Among authors: oki e. Dis Esophagus. 2010 Jan;23(1):59-63. doi: 10.1111/j.1442-2050.2009.00973.x. Epub 2009 Apr 15. Dis Esophagus. 2010. PMID: 19392844

7

Phase II study of biweekly docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer.

Kakeji Y, Oki E, Egashira A, Sadanaga N, Takahashi I, Morita M, Emi Y, Maehara Y. Kakeji Y, et al. Among authors: oki e. Oncology. 2009;77(1):49-52. doi: 10.1159/000226111. Epub 2009 Jun 25. Oncology. 2009. PMID: 19556809 Clinical Trial.

8

Chemosensitivity and survival in gastric cancer patients with microsatellite instability.

Oki E, Kakeji Y, Zhao Y, Yoshida R, Ando K, Masuda T, Ohgaki K, Morita M, Maehara Y. Oki E, et al. Ann Surg Oncol. 2009 Sep;16(9):2510-5. doi: 10.1245/s10434-009-0580-8. Epub 2009 Jun 30. Ann Surg Oncol. 2009. PMID: 19565284

9

The impact of a high-frequency microsatellite instability phenotype on the tumor location-related genetic differences in colorectal cancer.

Zhao Y, Oki E, Ando K, Morita M, Kakeji Y, Maehara Y. Zhao Y, et al. Among authors: oki e. Cancer Genet Cytogenet. 2010 Jan 15;196(2):133-9. doi: 10.1016/j.cancergencyto.2009.09.009. Cancer Genet Cytogenet. 2010. PMID: 20082848

10

High expression of BUBR1 is one of the factors for inducing DNA aneuploidy and progression in gastric cancer.

Ando K, Kakeji Y, Kitao H, Iimori M, Zhao Y, Yoshida R, Oki E, Yoshinaga K, Matumoto T, Morita M, Sakaguchi Y, Maehara Y. Ando K, et al. Among authors: oki e. Cancer Sci. 2010 Mar;101(3):639-45. doi: 10.1111/j.1349-7006.2009.01457.x. Epub 2009 Dec 4. Cancer Sci. 2010. PMID: 20132214 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

642 results

Search Page

Filters